中华顶尖财经--信息搜索

信息搜索

信息关键字：医

『查询2022年信息』『查询2021年信息』『查询2020年信息』『查询2019年信息』『查询2018年信息』『查询2017年信息』『查询2016年信息』
『查询2015年信息』『查询2014年信息』『查询2013年信息』『查询2012年信息』『查询2011年信息』『查询2010年信息』『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]

·李在明绝食第19天健康恶化被送医2023-9-18 7:50:42

·恒瑞医药与子公司瑞石生物部分股东产生分歧？瑞石生物在职人员称“原有员工或被遣散”2023-9-18 1:51:06

·医药行业周报：精选医药底部个股2023-9-17 18:23:08

·中国生物：与军事医学研究院合作将解决国内尚无特异性抗猴痘病毒药物局面2023-9-16 16:14:10

·佰仁医疗（688198）9月15日主力资金净买入59.82万元2023-9-16 11:05:58

·鲁抗医药：子公司药品通过仿制药一致性评价2023-9-15 17:22:24

·9月15日冠福股份涨停分析：医药，化学原料药，维生素概念热股2023-9-15 16:48:54

·9月15日易明医药涨停分析：医药，中药，西藏概念热股2023-9-15 16:44:43

·9月15日双成药业涨停分析：阿尔茨海默病，肝炎概念，医药概念热股2023-9-15 16:36:26

·9月15日莱美药业涨停分析：眼科，医药概念热股2023-9-15 16:28:20

·9月15日通化金马涨停分析：阿尔茨海默病，林业，医药概念热股2023-9-15 16:19:41

·恩威医药：对乙酰氨基酚布洛芬片研发获得境内生产药品注册上市许可《受理通知书》2023-9-15 16:19:35

·医药生物行业基金专题报告：拨开迷雾，见微知著2023-9-15 16:15:45

·9月15日东方嘉盛涨停分析：医药，疫苗，自由贸易港概念热股2023-9-15 15:51:16

·恒瑞医药子公司瑞石生物解散？内部人士：影响有限2023-9-15 15:13:43

·湖南省常德市第二中医医院原院长陈文清接受审查调查2023-9-15 14:55:31

·商贸零售行业点评报告：医美化妆品8月月报：科笛外用非那雄胺喷雾剂取得新进展，化妆品淡季背景下延续温和复苏2023-9-15 14:13:55

·复星医药：未来三年创新产品销售收入年复合增长率将保持不低于25%2023-9-15 13:52:34

·恒瑞医药子公司“解散、发生冲突”？现场人士：有纠纷，在等通知2023-9-15 13:51:14

·科伦药业：子公司与西南医科大学附属医院就放射性核素药物偶联物TBM2023-9-15 13:36:07

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]